Elanco Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Elanco Animal Health
ELAN Stock  USD 24.31  0.09  0.37%   
Elanco Animal's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Elanco Animal's valuation are provided below:
Gross Profit
2.5 B
Profit Margin
0.0078
Market Capitalization
12.1 B
Enterprise Value Revenue
3.4072
Revenue
4.6 B
We have found one hundred twenty available fundamental signals for Elanco Animal Health, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to verify Elanco Animal's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.

Elanco Animal Total Revenue

3.98 Billion

Check Elanco Animal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elanco Animal's main balance sheet or income statement drivers, such as Tax Provision of 181.1 M, Depreciation And Amortization of 516 M or Interest Expense of 409.3 M, as well as many indicators such as Price To Sales Ratio of 1.47, Dividend Yield of 0.0 or PTB Ratio of 1.68. Elanco financial statements analysis is a perfect complement when working with Elanco Animal Valuation or Volatility modules.
  
Build AI portfolio with Elanco Stock
Check out the analysis of Elanco Animal Correlation against competitors.

Elanco Animal Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding457.5 M571.9 M410 M
Slightly volatile
Total Assets13.6 B14.5 B11.1 B
Slightly volatile
Other Current Liabilities844 M1.1 B657 M
Slightly volatile
Total Current Liabilities1.3 B1.5 B1 B
Slightly volatile
Total Stockholder Equity5.4 B5.5 B6.7 B
Slightly volatile
Other Liabilities780.6 M1.1 B672.3 M
Slightly volatile
Property Plant And Equipment Net1.1 B1.1 B918.4 M
Slightly volatile
Accounts Payable334 M340.4 M281 M
Slightly volatile
Cash450.9 M538.2 M366.5 M
Slightly volatile
Non Current Assets Total10.5 B10.8 B8.5 B
Slightly volatile
Non Currrent Assets Other305.8 M357.6 M258.2 M
Slightly volatile
Other Assets123.4 M173.7 M175.7 M
Slightly volatile
Cash And Short Term Investments450.9 M538.2 M366.5 M
Slightly volatile
Net Receivables957.6 M1 B799.7 M
Slightly volatile
Good Will4.8 B5.1 B3.8 B
Slightly volatile
Liabilities And Stockholders Equity13.6 B14.5 B11.1 B
Slightly volatile
Non Current Liabilities Total4.8 B6 B3.1 B
Slightly volatile
Inventory1.4 B1.8 B1.2 B
Slightly volatile
Other Current Assets272.4 M330.1 M230.9 M
Slightly volatile
Other Stockholder Equity7.6 B10.1 B7.3 B
Slightly volatile
Total Liabilities6.2 B7.5 B4.2 B
Slightly volatile
Long Term Investments15.9 M24.3 M15.1 M
Slightly volatile
Property Plant And Equipment Gross1.5 B2.1 B1.2 B
Slightly volatile
Total Current Assets3.1 B3.7 B2.6 B
Slightly volatile
Non Current Liabilities Other243.3 M347.3 M191.2 M
Slightly volatile
Intangible Assets4.3 B4.2 B3.5 B
Slightly volatile
Common Stock8.5 B9.3 B7.9 B
Slightly volatile
Property Plant Equipment1.1 B1.1 B934.4 M
Slightly volatile
Net Invested Capital12 B12 B9.8 B
Slightly volatile
Net Working Capital1.8 B2.2 B1.6 B
Slightly volatile
Short and Long Term Debt Total5.2 B5 B3.7 B
Slightly volatile
Current Deferred Revenue632.7 M602.6 M386.2 M
Slightly volatile
Long Term Debt5 B4.9 B3.6 B
Slightly volatile
Long Term Debt Total1.9 B2.1 B2.4 B
Slightly volatile
Capital Surpluse8.2 B10 B6.8 B
Slightly volatile
Short and Long Term Debt37.6 M39.6 M98.9 M
Slightly volatile
Short Term Debt37.6 M39.6 M98.9 M
Slightly volatile
Short Term Investments11.2 M12.6 M13.8 M
Slightly volatile

Elanco Animal Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization516 M761.3 M420.8 M
Slightly volatile
Selling General Administrative1 B1.2 B951.7 M
Slightly volatile
Total Revenue4 B5.1 B3.5 B
Slightly volatile
Gross Profit1.7 B2.2 B1.5 B
Slightly volatile
Other Operating Expenses3.7 B4.8 B3.3 B
Slightly volatile
Research Development331.5 M395.6 M305.6 M
Slightly volatile
Cost Of Revenue2.3 B2.9 B2 B
Slightly volatile
Total Operating Expenses1.5 B1.9 B1.3 B
Slightly volatile
Reconciled Depreciation533.9 M761.3 M435.7 M
Slightly volatile
Extraordinary Items26.5 M29.8 M32.5 M
Slightly volatile
Interest Income59.7 M90.7 M52.4 M
Slightly volatile
Non Recurring384.8 M210.4 M220 M
Slightly volatile
Selling And Marketing Expenses302.1 M212.4 M727.2 M
Slightly volatile

Elanco Animal Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation44.8 M63.2 M34.2 M
Slightly volatile
Begin Period Cash Flow442.5 M404.8 M320.6 M
Slightly volatile
Depreciation516 M761.3 M420.8 M
Slightly volatile
Capital Expenditures179.7 M169.1 M146.1 M
Slightly volatile
End Period Cash Flow481.1 M538.2 M452.7 M
Very volatile
Sale Purchase Of Stock1.2 B1.1 B1.4 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.471.553.3218
Slightly volatile
PTB Ratio1.681.131.6181
Slightly volatile
Days Sales Outstanding95.7483.7884.5259
Slightly volatile
Book Value Per Share18.0514.1917.5497
Slightly volatile
Stock Based Compensation To Revenue0.00870.01120.009
Slightly volatile
Capex To Depreciation0.420.260.39
Slightly volatile
PB Ratio1.681.131.6181
Slightly volatile
EV To Sales4.22.553.9406
Slightly volatile
Inventory Turnover1.791.851.7121
Slightly volatile
Days Of Inventory On Hand182204215
Pretty Stable
Payables Turnover5.867.697.1208
Very volatile
Sales General And Administrative To Revenue0.190.220.2372
Slightly volatile
Research And Ddevelopement To Revenue0.09330.08910.0901
Slightly volatile
Capex To Revenue0.03690.02980.0411
Pretty Stable
Cash Per Share1.081.090.9048
Slightly volatile
Days Payables Outstanding57.9949.1152.8223
Very volatile
Intangibles To Total Assets0.530.580.6401
Pretty Stable
Current Ratio2.782.812.7766
Slightly volatile
Receivables Turnover3.434.514.3711
Slightly volatile
Graham Number8.4812.411.1137
Slightly volatile
Shareholders Equity Per Share18.0514.1917.5497
Slightly volatile
Debt To Equity0.560.640.5828
Slightly volatile
Capex Per Share0.310.270.3478
Pretty Stable
Revenue Per Share6.948.098.3886
Very volatile
Interest Debt Per Share8.748.499.2677
Slightly volatile
Debt To Assets0.270.310.3046
Slightly volatile
Operating Cycle252270297
Pretty Stable
Price Book Value Ratio1.681.131.6181
Slightly volatile
Days Of Payables Outstanding57.9949.1152.8223
Very volatile
Company Equity Multiplier1.461.861.5684
Slightly volatile
Long Term Debt To Capitalization0.320.370.3544
Slightly volatile
Total Debt To Capitalization0.330.370.3598
Slightly volatile
Debt Equity Ratio0.560.640.5828
Slightly volatile
Quick Ratio1.51.441.5036
Slightly volatile
Net Income Per E B T1.140.80.9647
Very volatile
Cash Ratio0.410.35590.3896
Slightly volatile
Cash Conversion Cycle209232245
Pretty Stable
Days Of Inventory Outstanding182204215
Pretty Stable
Days Of Sales Outstanding95.7483.7884.5259
Slightly volatile
Price To Book Ratio1.681.131.6181
Slightly volatile
Fixed Asset Turnover3.014.023.788
Very volatile
Debt Ratio0.270.310.3046
Slightly volatile
Price Sales Ratio1.471.553.3218
Slightly volatile
Asset Turnover0.340.40.3343
Pretty Stable
Gross Profit Margin0.340.390.418
Pretty Stable
Price Fair Value1.681.131.6181
Slightly volatile

Elanco Fundamental Market Drivers

Forward Price Earnings23.2558
Cash And Short Term Investments468 M

Elanco Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Elanco Animal Financial Statements

Elanco Animal investors utilize fundamental indicators, such as revenue or net income, to predict how Elanco Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue602.6 M632.7 M
Total Revenue5.1 B4 B
Cost Of Revenue2.9 B2.3 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.22  0.19 
Research And Ddevelopement To Revenue 0.09  0.09 
Capex To Revenue 0.03  0.04 
Revenue Per Share 8.09  6.94 
Ebit Per Revenue 0.05  0.05 

Pair Trading with Elanco Animal

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elanco Animal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elanco Animal will appreciate offsetting losses from the drop in the long position's value.

Moving together with Elanco Stock

  0.7JNJ Johnson JohnsonPairCorr
  0.86LPCN LipocinePairCorr

Moving against Elanco Stock

  0.8HPQ HP IncPairCorr
  0.69MSFT MicrosoftPairCorr
  0.41BRK-A Berkshire HathawayPairCorr
  0.37VLCN Volcon Inc Symbol ChangePairCorr
  0.36MMM 3M CompanyPairCorr
The ability to find closely correlated positions to Elanco Animal could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elanco Animal when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elanco Animal - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elanco Animal Health to buy it.
The correlation of Elanco Animal is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elanco Animal moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elanco Animal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elanco Animal can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Elanco Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elanco Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elanco Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elanco Animal Health Stock:
How To Invest In Elanco
Details
Is Elanco Stock a good investment?
Details
What is Elanco Animal's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Elanco Animal Correlation against competitors.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Will Pharmaceuticals sector continue expanding? Could Elanco diversify its offerings? Factors like these will boost the valuation of Elanco Animal. Projected growth potential of Elanco fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Elanco Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
1.167
Earnings Share
0.07
Revenue Per Share
9.261
Quarterly Revenue Growth
0.104
Return On Assets
0.0115
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Elanco Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Elanco Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Elanco Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY